
-
Napoli give Serie A leaders Inter a let-off with Bologna draw
-
'Taxi Driver' writer accused of sexual harassment and assault
-
US Supreme Court pauses order for return of Salvadoran deported in error
-
Scheffler and McIlroy chase history at Masters
-
No.3 Schauffele likes chance of third win in four majors
-
Trump announces direct Iran talks, at meeting with Netanyahu
-
Indigenous leaders want same clout as world leaders at UN climate talks
-
Palestinians in West Bank strike to demand end to Gaza war
-
Woods teams with Augusta National on course design, school project
-
Real Madrid goalkeeper Courtois fit to face Arsenal in Champions League
-
Masters halts practice for the day and evacuates spectators
-
Kane in 'top three' for Ballon d'Or, says Klinsmann
-
Bengaluru edge Mumbai to spoil Bumrah's return in IPL
-
Medvedev battles past Khachanov at Monte Carlo
-
Montpellier axe coach Gasset as Ligue 1 relegation looms
-
US 'turns a blind eye', says American-Palestinian after son killed by Israel
-
France, Egypt, Jordan say Palestinian Authority must head post-war Gaza
-
Netanyahu meets Trump for tariff and Gaza talks
-
Night at the museum: UK's National Gallery offering guest sleepover
-
airBaltic CEO 'dismissed' from Latvian airline
-
German police earn their stripes with zebra-loaded van stop
-
'Bloodbath': Spooked Republicans warn Trump over US tariffs
-
Trump vows huge new China tariffs as markets nosedive
-
Belgian prince loses legal quest for social security
-
Facing Trump's trade war, EU seeks to quell divisions
-
France detains alleged Romanian royal wanted in home country
-
Van Dijk reveals 'progress' in talks over new Liverpool contract
-
Starmer unveils support for tariff-hit auto sector
-
Clem Burke, drummer for Blondie, dies at 70
-
Dortmund defender Schlotterbeck ruled out for season with injury
-
Arteta says Arsenal can upset Real Madrid on 'biggest night' of career
-
Bayern will not 'change goals' despite injury woes, says Kompany
-
Inter captain Martinez fined 5,000 euros for blasphemy
-
Netanyahu to plead with Trump for tariff break
-
Arsenal's Saka says injury break 'really good' mentally
-
EU funding of NGOs 'too opaque', auditors find amid political storm
-
La Liga appeal decision allowing Barcelona's Olmo to play again
-
JPMorgan Chase CEO warns tariffs will slow growth
-
World sport-starved Moscow cheers Ovechkin NHL record
-
Stocks sink again as Trump holds firm on tariffs
-
Trump warns against 'stupid' panic as markets plummet
-
Thousands of Afghans depart Pakistan under repatriation pressure
-
Macron rejects any Hamas role in post-war Gaza
-
EU split on targeting US tech over Trump tariffs
-
Russia, accused of stalling, wants answers before truce
-
German climate activist faces expulsion from Austria after ban
-
Southampton sack manager Juric after Premier League relegation
-
Fowler hits the target as Matildas down South Korea
-
Brook named new England white-ball cricket captain
-
Honda executive resigns over 'inappropriate conduct'
RIO | -0.2% | 54.56 | $ | |
CMSC | -0.54% | 22.17 | $ | |
NGG | -4.82% | 62.9 | $ | |
BTI | -1.09% | 39.43 | $ | |
SCS | -3.73% | 10.2 | $ | |
GSK | -4.85% | 34.84 | $ | |
CMSD | -1.56% | 22.48 | $ | |
RYCEF | -0.24% | 8.23 | $ | |
BCC | -3.86% | 91.89 | $ | |
RBGPF | 1.48% | 69.02 | $ | |
BP | -4.45% | 27.17 | $ | |
BCE | -2.85% | 22.08 | $ | |
VOD | -1.8% | 8.35 | $ | |
AZN | -4.06% | 65.79 | $ | |
JRI | -6.22% | 11.26 | $ | |
RELX | -5.78% | 45.53 | $ |

EU eyes autumn approval of Pfizer jab for Covid variants
The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech Covid vaccine adapted for two fast-spreading subvariants of the Omicron strain.
Milder but more infectious than earlier types of the Covid virus, the BA.4 and BA.5 types have helped to drive a wave of new cases of the disease in Europe and the United States.
The European Medicines Agency (EMA) said it had launched a review on Monday of an adapted version of the Pfizer jab targeting those two types, which are more transmissible and immune evasive than earlier variants.
"EMA is expecting to receive an application for the BA.4/5 adapted vaccine developed by Pfizer/BioNTech, which will be evaluated for a potential rapid approval in the fall," an EMA spokesman told AFP in an emailed statement.
That would come "shortly after" the expected approval of two other adapted vaccines by Pfizer and its rival Moderna, which target both the original Covid virus and the earlier BA.1 subvariant of Omicron, the spokesman said.
Both Pfizer and Moderna had lodged separate applications for approval of those vaccines on July 22, the spokesman added.
The EMA, which oversees medicines for the 27-nation European Union, has previously said the first Omicron-adapted jabs could be approved as early as September.
- 'Nowhere near over' -
While vaccines have helped lower hospitalisations and deaths from Covid, which first emerged in China in late 2019, the current jabs are mainly aimed at the earlier strains of the disease.
The World Health Organization warned in July that the pandemic was "nowhere near over", due to the spread of Omicron subvariants and to the lifting of control measures.
Covid cases rose around the world in late spring and early summer, driven by the new variants, but have since started to plateau in Europe.
European nations are now starting to look ahead to the autumn and winter season, when cases are expected to peak once more.
The EU said on Tuesday it had agreed with Moderna to delay vaccine deliveries scheduled for the summer to wait for jabs that are adapted for new Omicron variants.
The WHO and the EU's health and medicine agencies have meanwhile all recently recommended a second booster shot for older people.
The BA.4 and BA.5 variants were first discovered in South Africa and spread rapidly despite high population immunity conferred by prior waves and vaccinations.
Like other Omicron variants, they tend to have a milder disease course as they settle less in the lungs and more in the upper nasal passages, causing symptoms like fever, tiredness and loss of smell.
A.Seabra--PC